{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:21:38Z","timestamp":1790706098927,"version":"4.1.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin City","doi-asserted-by":"publisher","award":["19JCYBJC26500"],"award-info":[{"award-number":["19JCYBJC26500"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Diffuse large B-cell lymphoma (DLBCL) is a biologically and clinically heterogeneous disease that requires personalized clinical treatment. To assign patients into different risk categories, cytogenetic abnormalities and genetic mutations have been widely applied to the prognostic stratification of DLBCL. Increasing evidence has demonstrated that deregulated epigenetic modifications and long noncoding RNAs (lncRNAs) contribute to the initiation and progression of DLBCL. However, specific lncRNAs that affect epigenetic regulation and their value in predicting prognosis and therapy response remain uncertain. Here, 2,025 epigenetic-related genes were selected, and 9 lncRNAs (PRKCQ-AS1, C22orf34, HCP5, AC007389.3, APTR, SNHG19, ELFN1-AS1, LINC00487, and LINC00877) were tested and validated to establish an lncRNA-regulating epigenetic event signature (ELncSig). ELncSig, which was established based on independent lymphoma datasets, could distinguish different survival outcomes. Functional characterization of ELncSig showed that it could be an indicator of the immune microenvironment and is correlated with distinctive mutational characteristics. Univariate and multivariate analyses showed that ELncSig was independent of traditional prognostic factors. The novel immune-related ELncSig exhibits promising clinical prognostic value for DLBCL.<\/jats:p>","DOI":"10.3389\/fimmu.2022.813031","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T16:42:01Z","timestamp":1657125721000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["A 9-LncRNA Signature for Predicting Prognosis and Immune Response in Diffuse Large B-Cell Lymphoma"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiaoxuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxiao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongli","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiubao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/35000501","article-title":"Distinct Types of Diffuse Large B-Cell Lymphoma Identified by Gene Expression Profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2174\/1568009620666210106122750","article-title":"Epigenetic Mechanisms of Therapy Resistance in Diffuse Large B Cell Lymphoma (DLBCL)","volume":"21","author":"Isshiki","year":"2021","journal-title":"Curr Cancer Drug Targets"},{"key":"B4","doi-asserted-by":"publisher","first-page":":123","DOI":"10.1038\/s41408-020-00389-w","article-title":"Genetic and Epigenetic Determinants of Diffuse Large B-Cell Lymphoma","volume":"10","author":"Bakhshi","year":"2020","journal-title":"Blood Cancer J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.immuni.2019.08.006","article-title":"Unique and Shared Epigenetic Programs of the CREBBP and EP300 Acetyltransferases in Germinal Center B Cells Reveal Targetable Dependencies in Lymphoma","volume":"51","author":"Meyer","year":"2019","journal-title":"Immunity"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000847","article-title":"The Immune Landscape and Response to Immune Checkpoint Blockade Therapy in Lymphoma","volume":"135","author":"Kline","year":"2020","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/sj.leu.2404970","article-title":"Lymphoma Microenvironment: Culprit or Innocent","volume":"22","author":"Herreros","year":"2008","journal-title":"Leukemia"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2019.05.001","article-title":"Targeting the Tumor Microenvironment of Leukemia and Lymphoma","volume":"5","author":"Hopken","year":"2019","journal-title":"Trends Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0225-1","article-title":"Genetic Alterations and Their Clinical Implications in DLBCL","volume":"16","author":"Miao","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":":e000110","DOI":"10.1136\/jitc-2019-000110","article-title":"Identification of Tumor Immune Infiltration-Associated lncRNAs for Improving Prognosis and Immunotherapy Response of Patients With non-Small Cell Lung Cancer","volume":"8","author":"Sun","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":":bbaa047","DOI":"10.1093\/bib\/bbaa047","article-title":"Computational Recognition of lncRNA Signature of Tumor-Infiltrating B Lymphocytes With Potential Implications in Prognosis and Immunotherapy of Bladder Cancer","volume":"22","author":"Zhou","year":"2021","journal-title":"Brief Bioinform"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal Gene Signatures in Large-B-Cell Lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.83","article-title":"Comprehensive Gene Expression Profiling and Immunohistochemical Studies Support Application of Immunophenotypic Algorithm for Molecular Subtype Classification in Diffuse Large B-Cell Lymphoma: A Report From the International DLBCL Rituximab-CHOP Consortium Program Study","volume":"26","author":"Visco","year":"2012","journal-title":"Leukemia"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape Provides a Biologist-Oriented Resource for the Analysis of Systems-Level Datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/s0140-6736(85)91128-6","article-title":"Nomogram for Predictive Values and Efficiencies of Tests","volume":"1","author":"Moller-Petersen","year":"1985","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00274-6","article-title":"Nomograms to Predict Outcomes After (177)Lu-PSMA Therapy in Men With Metastatic Castration-Resistant Prostate Cancer: An International, Multicentre, Retrospective Study","volume":"22","author":"Gafita","year":"2021","journal-title":"Lancet Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"Limma Powers Differential Expression Analyses for RNA-Sequencing and Microarray Studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/nature08460","article-title":"Systematic RNA Interference Reveals That Oncogenic KRAS-Driven Cancers Require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse Large B-Cell Lymphoma","volume":"384","author":"Sehn","year":"2021","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: Efficient and Comprehensive Analysis of Somatic Variants in Cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.patrec.2005.10.010","article-title":"An Introduction to ROC Analysis","volume":"27","author":"Fawcett","year":"2006","journal-title":"Pattern Recogn Lett"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337","article-title":"Robust Enumeration of Cell Subsets From Tissue Expression Profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2021.109779","article-title":"Diffuse Large B-Cell Lymphoma-Derived Exosomes Push Macrophage Polarization Toward M2 Phenotype via GP130\/STAT3 Signaling Pathway","volume":"352","author":"Ling","year":"2022","journal-title":"Chem Biol Interact"},{"key":"B24","doi-asserted-by":"publisher","first-page":":e004114","DOI":"10.1136\/jitc-2021-004114","article-title":"Genetic Characteristics Involving the PD-1\/PD-L1\/L2 and CD73\/A2aR Axes and the Immunosuppressive Microenvironment in DLBCL","volume":"10","author":"Zhang","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring Tumour Purity and Stromal and Immune Cell Admixture From Expression Data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3380","article-title":"Immunogenic Cell Death and DAMPs in Cancer Therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and Activity of Anti-PD-L1 Antibody in Patients With Advanced Cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2020.0073","article-title":"Single-Cell RNA-Seq Reveals the Immune Escape and Drug Resistance Mechanisms of Mantle Cell Lymphoma","volume":"17","author":"Wang","year":"2020","journal-title":"Cancer Biol Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma With Therapeutic Implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-1448","article-title":"CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade","volume":"10","author":"Wang","year":"2020","journal-title":"Cancer Discovery"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.214122","article-title":"MYD88 Mutations Identify a Molecular Subgroup of Diffuse Large B-Cell Lymphoma With an Unfavorable Prognosis","volume":"105","author":"Vermaat","year":"2020","journal-title":"Haematologica"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2242-9","article-title":"Oncogenic MYD88 Mutations in Lymphoma: Novel Insights and Therapeutic Possibilities","volume":"67","author":"Weber","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4198","article-title":"PIM1 Kinase Regulates Cell Death, Tumor Growth and Chemotherapy Response in Triple-Negative Breast Cancer","volume":"22","author":"Braso-Maristany","year":"2016","journal-title":"Nat Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.221","article-title":"Influence of Oncogenic Mutations and Tumor Microenvironment Alterations on Extranodal Invasion in Diffuse Large B-Cell Lymphoma","volume":"10","author":"Shen","year":"2020","journal-title":"Clin Transl Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1806191","article-title":"Genetics of Diffuse Large B-Cell Lymphoma","volume":"379","author":"Wright","year":"2018","journal-title":"N Engl J Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0754-8","article-title":"The Novel lncRNA BlackMamba Controls the Neoplastic Phenotype of ALK(-) Anaplastic Large Cell Lymphoma by Regulating the DNA Helicase HELLS","volume":"34","author":"Fragliasso","year":"2020","journal-title":"Leukemia"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.51329","article-title":"Geniposide Inhibits Proliferation and Induces Apoptosis of Diffuse Large B-Cell Lymphoma Cells by Inactivating the HCP5\/miR-27b-3p\/MET Axis","volume":"17","author":"Hu","year":"2020","journal-title":"Int J Med Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2020.98839","article-title":"Construction of Relapse-Related lncRNA-Mediated ceRNA Networks in Hodgkin Lymphoma","volume":"16","author":"Liang","year":"2020","journal-title":"Arch Med Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":":634","DOI":"10.3390\/cancers14030634","article-title":"Identification of Circulating lncRNAs Associated With Gallbladder Cancer Risk by Tissue-Based Preselection, Cis-eQTL Validation, and Analysis of Association With Genotype-Based Expression","volume":"14","author":"Blandino","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"8998","DOI":"10.1002\/jcp.27572","article-title":"Long Noncoding RNA APTR Contributes to Osteosarcoma Progression Through Repression of miR-132-3p and Upregulation of Yes-Associated Protein 1","volume":"234","author":"Guan","year":"2019","journal-title":"J Cell Physiol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.536346","article-title":"LncRNA APTR Promotes Uterine Leiomyoma Cell Proliferation by Targeting ERalpha to Activate the Wnt\/beta-Catenin Pathway","volume":"11","author":"Zhou","year":"2021","journal-title":"Front Oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":":8970340","DOI":"10.1155\/2020\/8970340","article-title":"Identification of Long Noncoding RNAs as Predictors of Survival in Triple-Negative Breast Cancer Based on Network Analysis","volume":"2020","author":"Li","year":"2020","journal-title":"BioMed Res Int"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3233\/CBM-210393","article-title":"lncRNA ELFN1-AS1 Predicts Poor Prognosis and Promotes Tumor Progression of Non-Small Cell Lung Cancer by Sponging miR-497","author":"Yang","year":"2022","journal-title":"Cancer Biomark"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3892\/or.2020.7528","article-title":"Risk Scoring Based on Expression of Long Non-Coding RNAs can Effectively Predict Survival in Hepatocellular Carcinoma Patients With or Without Fibrosis","volume":"43","author":"Ye","year":"2020","journal-title":"Oncol Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01048","article-title":"Long Non-Coding RNAs in Myeloid Malignancies","volume":"9","author":"Zimta","year":"2019","journal-title":"Front Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-3302","article-title":"ColoGuidePro: A Prognostic 7-Gene Expression Signature for Stage III Colorectal Cancer Patients","volume":"18","author":"Sveen","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3940","article-title":"Disruption of KMT2D Perturbs Germinal Center B Cell Development and Promotes Lymphomagenesis","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nature09671","article-title":"Oncogenically Active MYD88 Mutations in Human Lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-09-672352","article-title":"Diffuse Large B-Cell Lymphoma Patient-Derived Xenograft Models Capture the Molecular and Biological Heterogeneity of the Disease","volume":"127","author":"Chapuy","year":"2016","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 Blockade With Nivolumab in Relapsed or Refractory Hodgkin\u2019s Lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"N Engl J Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-0268","article-title":"Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy","volume":"71","author":"Halama","year":"2011","journal-title":"Cancer Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.813031\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T16:42:09Z","timestamp":1657125729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.813031\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2022.813031"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.813031","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"article-number":"813031"}}